Trial intelligence / Profile preview

Methotrexate for glucocorticoid reduction in recently diagnosed polymyalgia rheumatica

NL-OMON54851Phase 3Active, not recruiting

Sponsor
Sint Maartenskliniek
Start
Apr 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of methotrexate in polymyalgia rheumatica (PMR), sponsored by Sint Maartenskliniek. Started Apr 2020; status: active, not recruiting.

02

Drugs

methotrexate
03

Conditions

polymyalgia rheumatica (PMR)

Beyond the preview

Go deeper on NL-OMON54851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON54851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call